Medifast outlines $270M–$300M 2026 revenue target as CEO transition and metabolic health focus drive execution (NYSE:MED)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...